136 related articles for article (PubMed ID: 7921730)
1. Treating negative symptoms.
Bailey P; Duval F; Macher JP
Br J Psychiatry; 1994 May; 164(5):699-700. PubMed ID: 7921730
[No Abstract] [Full Text] [Related]
2. Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial.
Duinkerke SJ; Botter PA; Jansen AA; van Dongen PA; van Haaften AJ; Boom AJ; van Laarhoven JH; Busard HL
Br J Psychiatry; 1993 Oct; 163():451-5. PubMed ID: 7902766
[TBL] [Abstract][Full Text] [Related]
3. The treatment of negative symptoms: pharmacological and methodological issues.
Carpenter WT
Br J Psychiatry Suppl; 1996 May; (29):17-22. PubMed ID: 8733819
[No Abstract] [Full Text] [Related]
4. [Deficit schizophrenias].
Puech AJ
Encephale; 1996 Jun; 22 Spec No 2():1. PubMed ID: 8767033
[No Abstract] [Full Text] [Related]
5. [Effect of neuroleptics on depressive symptoms].
Tabeze JP
Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
[No Abstract] [Full Text] [Related]
6. [Depressive symptoms in schizophrenia].
Gerard A
Encephale; 1998 Jul; 24 Spec No 1():24-6. PubMed ID: 9809250
[No Abstract] [Full Text] [Related]
7. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
8. An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.
Wiesel FA; Nordström AL; Farde L; Eriksson B
Psychopharmacology (Berl); 1994 Feb; 114(1):31-8. PubMed ID: 7846205
[TBL] [Abstract][Full Text] [Related]
9. Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Akhondzadeh S; Malek-Hosseini M; Ghoreishi A; Raznahan M; Rezazadeh SA
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1879-83. PubMed ID: 18801405
[TBL] [Abstract][Full Text] [Related]
10. Psychotropic effects of ritanserin, a selective S2 antagonist: an open study.
Strauss WH; Klieser E
Eur Neuropsychopharmacol; 1991 May; 1(2):101-5. PubMed ID: 1821698
[TBL] [Abstract][Full Text] [Related]
11. [Methodological constraints in evaluating anti-deficit effects].
Boyer P; Lecrubier Y; Rein W
Encephale; 1996 Jun; 22 Spec No 2():25-7. PubMed ID: 8767038
[TBL] [Abstract][Full Text] [Related]
12. Depressive symptoms and schizophrenia a psychopharmacological approach.
Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
[TBL] [Abstract][Full Text] [Related]
13. Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial.
Leiderman E; Zylberman I; Zukin SR; Cooper TB; Javitt DC
Biol Psychiatry; 1996 Feb; 39(3):213-5. PubMed ID: 8837983
[No Abstract] [Full Text] [Related]
14. [Schizophrenic deficit syndrome and neurologic tolerance].
Verdoux H; Bourgeois M
Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and treatment of negative symptoms.
Villeneuve A
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
[TBL] [Abstract][Full Text] [Related]
16. Novel antipsychotics and negative symptoms.
Möller HJ
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S43-7. PubMed ID: 9690970
[TBL] [Abstract][Full Text] [Related]
17. L-deprenyl in treating negative symptoms of schizophrenia.
Perenyi A; Goswami U; Frecska E; Arató M; Bela A
Psychiatry Res; 1992 May; 42(2):189-91. PubMed ID: 1352903
[No Abstract] [Full Text] [Related]
18. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
Barnes TR; Liddle PF; Curson DA; Patel M
Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
[No Abstract] [Full Text] [Related]
19. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome.
Tamminga CA; Buchanan RW; Gold JM
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S21-6. PubMed ID: 9690966
[TBL] [Abstract][Full Text] [Related]
20. Battle against therapeutic nihilism in caring for patients who exhibit the negative symptoms of schizophrenia (NSS).
Bermanzohn PC; Siris SG
Compr Psychiatry; 1994; 35(6):478. PubMed ID: 7867322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
